SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3nhe'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E71_M_ASCM995_0 (MYROSINASE MA1)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 7	ILE A 411 PHE A 318 PHE A 339 PHE A 361	None	1.03A	1e71M-3nheA: undetectable	1e71M-3nheA: 19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E72_M_ASCM995_0 (MYROSINASE MA1)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 7	ILE A 411 PHE A 318 PHE A 339 PHE A 361	None	1.02A	1e72M-3nheA: undetectable	1e72M-3nheA: 19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1TV8_B_SAMB2501_0 (MOLYBDENUM COFACTOR BIOSYNTHESIS PROTEIN A)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 7	TYR A 294 THR A 327 THR A 324 MET A 301	None	1.24A	1tv8B-3nheA: undetectable	1tv8B-3nheA: 20.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_P_CHDP4271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE III CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 8	LYS A 420 LEU A 419 GLN A 492 PHE A 438	None	0.93A	1v54P-3nheA: undetectable 1v54W-3nheA: undetectable	1v54P-3nheA: 20.23 1v54W-3nheA: 10.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CL5_B_SAMB1217_1 (CATECHOL O-METHYLTRANSFERASE)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 6	SER A 421 SER A 442 GLN A 359 ASP A 436	None	1.34A	2cl5B-3nheA: undetectable	2cl5B-3nheA: 19.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_P_CHDP1271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 8	LYS A 420 LEU A 419 GLN A 492 PHE A 438	None	0.91A	2dyrP-3nheA: undetectable 2dyrW-3nheA: undetectable	2dyrP-3nheA: 20.23 2dyrW-3nheA: 10.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_P_CHDP1271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 8	LYS A 420 LEU A 419 GLN A 492 PHE A 438	None	0.93A	2eikP-3nheA: undetectable 2eikW-3nheA: undetectable	2eikP-3nheA: 20.23 2eikW-3nheA: 10.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EJT_A_SAMA501_1 (N(2),N(2)-DIMETHYLGU ANOSINE TRNA METHYLTRANSFERASE)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	3 / 3	ARG A 493 ASP A 408 ASP A 303	None	0.78A	2ejtA-3nheA: undetectable	2ejtA-3nheA: 21.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W9S_A_TOPA1160_1 (DIHYDROFOLATE REDUCTASE TYPE 1 FROM TN4003)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	5 / 11	LEU A 500 LEU A 528 ILE A 491 PHE A 438 THR A 463	None	0.98A	2w9sA-3nheA: undetectable	2w9sA-3nheA: 20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W9S_B_TOPB1160_1 (DIHYDROFOLATE REDUCTASE TYPE 1 FROM TN4003)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	5 / 11	LEU A 500 LEU A 528 ILE A 491 PHE A 438 THR A 463	None	0.94A	2w9sB-3nheA: undetectable	2w9sB-3nheA: 20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W9S_D_TOPD1158_1 (DIHYDROFOLATE REDUCTASE TYPE 1 FROM TN4003)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	5 / 10	LEU A 500 LEU A 528 ILE A 491 PHE A 438 THR A 463	None	1.14A	2w9sD-3nheA: undetectable	2w9sD-3nheA: 20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W9S_F_TOPF1159_1 (DIHYDROFOLATE REDUCTASE TYPE 1 FROM TN4003)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	5 / 10	LEU A 500 LEU A 528 ILE A 491 PHE A 438 THR A 463	None	1.12A	2w9sF-3nheA: undetectable	2w9sF-3nheA: 20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZVJ_A_SAMA301_1 (CATECHOL O-METHYLTRANSFERASE)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 6	SER A 421 SER A 442 GLN A 359 ASP A 436	None	1.31A	2zvjA-3nheA: undetectable	2zvjA-3nheA: 19.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG2_C_CHDC271_0 (CYTOCHROME C OXIDASE SUBUNIT 3)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 7	LEU A 419 GLN A 492 PHE A 438 LEU A 441	None	1.01A	3ag2C-3nheA: undetectable	3ag2C-3nheA: 20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LN1_D_CELD682_2 (PROSTAGLANDIN G/H SYNTHASE 2)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 5	LEU A 598 ARG A 493 ILE A 491 PHE A 494	None	1.23A	3ln1D-3nheA: undetectable	3ln1D-3nheA: 21.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3X2Q_C_CHDC304_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 7	LEU A 419 GLN A 492 PHE A 438 LEU A 441	None	0.93A	3x2qC-3nheA: undetectable 3x2qJ-3nheA: undetectable	3x2qC-3nheA: 20.23 3x2qJ-3nheA: 10.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3X2Q_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 7	LEU A 419 GLN A 492 PHE A 438 LEU A 441	None	0.91A	3x2qP-3nheA: undetectable 3x2qW-3nheA: undetectable	3x2qP-3nheA: 20.23 3x2qW-3nheA: 10.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N09_A_ADNA401_2 (ADENOSINE KINASE)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 4	LEU A 502 SER A 442 LEU A 593 LEU A 455	None	1.01A	4n09A-3nheA: undetectable	4n09A-3nheA: 22.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OBW_A_SAMA602_1 (2-METHOXY-6-POLYPREN YL-1,4-BENZOQUINOL METHYLASE, MITOCHONDRIAL)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	3 / 3	ASP A 392 ASN A 535 SER A 421	None	0.86A	4obwA-3nheA: undetectable	4obwA-3nheA: 21.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1A_C_CHDC304_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 7	LEU A 419 GLN A 492 PHE A 438 LEU A 441	None	0.94A	5b1aC-3nheA: undetectable 5b1aJ-3nheA: undetectable	5b1aC-3nheA: 20.23 5b1aJ-3nheA: 10.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1A_P_CHDP305_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 7	LEU A 419 GLN A 492 PHE A 438 LEU A 441	None	0.87A	5b1aP-3nheA: undetectable 5b1aW-3nheA: undetectable	5b1aP-3nheA: 20.23 5b1aW-3nheA: 10.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B3S_C_CHDC307_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 7	LEU A 419 GLN A 492 PHE A 438 LEU A 441	None	0.90A	5b3sC-3nheA: undetectable 5b3sJ-3nheA: undetectable	5b3sC-3nheA: 20.23 5b3sJ-3nheA: 10.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B3S_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 3)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 7	LEU A 419 GLN A 492 PHE A 438 LEU A 441	None	0.90A	5b3sP-3nheA: undetectable	5b3sP-3nheA: 20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EVY_X_SALX502_1 (SALICYLATE HYDROXYLASE)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 5	SER A 286 GLN A 283 LEU A 266 PHE A 573	None	1.27A	5evyX-3nheA: undetectable	5evyX-3nheA: 21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5FHR_B_SAMB303_1 (CATECHOL O-METHYLTRANSFERASE)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 5	SER A 421 SER A 442 GLN A 359 ASP A 436	None	1.32A	5fhrB-3nheA: undetectable	5fhrB-3nheA: 19.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IL1_A_SAMA601_0 (METTL3)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	5 / 12	ILE A 343 LEU A 282 GLU A 360 PHE A 361 ARG A 363	None	1.18A	5il1A-3nheA: undetectable	5il1A-3nheA: 17.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IY5_C_CHDC307_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 7	LEU A 419 GLN A 492 PHE A 438 LEU A 441	None	0.87A	5iy5C-3nheA: undetectable 5iy5J-3nheA: undetectable	5iy5C-3nheA: 21.04 5iy5J-3nheA: 10.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5XU8_A_DX4A701_0 (UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	7 / 8	GLY A 268 LEU A 269 ASN A 279 SER A 280 GLN A 283 ALA A 560 PHE A 573	None None CME A 276 ( 4.0A) CME A 276 ( 4.5A) None None None	0.10A	5xu8A-3nheA: 49.3	5xu8A-3nheA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z84_C_CHDC307_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 7	LEU A 419 GLN A 492 PHE A 438 LEU A 441	None	0.93A	5z84C-3nheA: undetectable 5z84J-3nheA: undetectable	5z84C-3nheA: 20.23 5z84J-3nheA: 10.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z85_C_CHDC306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 7	LEU A 419 GLN A 492 PHE A 438 LEU A 441	None	0.94A	5z85C-3nheA: undetectable 5z85J-3nheA: undetectable	5z85C-3nheA: 20.23 5z85J-3nheA: 10.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCO_C_CHDC306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 7	LEU A 419 GLN A 492 PHE A 438 LEU A 441	None	0.92A	5zcoC-3nheA: undetectable 5zcoJ-3nheA: undetectable	5zcoC-3nheA: 20.23 5zcoJ-3nheA: 10.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCQ_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3nhe	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2 (Homo sapiens)	4 / 7	LEU A 419 GLN A 492 PHE A 438 LEU A 441	None	0.92A	5zcqP-3nheA: undetectable 5zcqW-3nheA: undetectable	5zcqP-3nheA: 20.23 5zcqW-3nheA: 10.64

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1E71_M_ASCM995_0","MYROSINASE MA1","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"ILE A 411;PHE A 318;PHE A 339;PHE A 361","None","1.03A","1e71M-3nheA:undetectable","1e71M-3nheA:19.57"],["1E72_M_ASCM995_0","MYROSINASE MA1","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"ILE A 411;PHE A 318;PHE A 339;PHE A 361","None","1.02A","1e72M-3nheA:undetectable","1e72M-3nheA:19.57"],["1TV8_B_SAMB2501_0","MOLYBDENUM COFACTOR BIOSYNTHESIS PROTEIN A","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"TYR A 294;THR A 327;THR A 324;MET A 301","None","1.24A","1tv8B-3nheA:undetectable","1tv8B-3nheA:20.60"],["1V54_P_CHDP4271_0","CYTOCHROME C OXIDASE POLYPEPTIDE III;CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"LYS A 420;LEU A 419;GLN A 492;PHE A 438","None","0.93A","1v54P-3nheA:undetectable;1v54W-3nheA:undetectable","1v54P-3nheA:20.23;1v54W-3nheA:10.64"],["2CL5_B_SAMB1217_1","CATECHOL O-METHYLTRANSFERASE","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"SER A 421;SER A 442;GLN A 359;ASP A 436","None","1.34A","2cl5B-3nheA:undetectable","2cl5B-3nheA:19.32"],["2DYR_P_CHDP1271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"LYS A 420;LEU A 419;GLN A 492;PHE A 438","None","0.91A","2dyrP-3nheA:undetectable;2dyrW-3nheA:undetectable","2dyrP-3nheA:20.23;2dyrW-3nheA:10.64"],["2EIK_P_CHDP1271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"LYS A 420;LEU A 419;GLN A 492;PHE A 438","None","0.93A","2eikP-3nheA:undetectable;2eikW-3nheA:undetectable","2eikP-3nheA:20.23;2eikW-3nheA:10.64"],["2EJT_A_SAMA501_1","N(2),N(2)-DIMETHYLGUANOSINE TRNA METHYLTRANSFERASE","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",3,"ARG A 493;ASP A 408;ASP A 303","None","0.78A","2ejtA-3nheA:undetectable","2ejtA-3nheA:21.09"],["2W9S_A_TOPA1160_1","DIHYDROFOLATE REDUCTASE TYPE 1 FROM TN4003","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",5,"LEU A 500;LEU A 528;ILE A 491;PHE A 438;THR A 463","None","0.98A","2w9sA-3nheA:undetectable","2w9sA-3nheA:20.93"],["2W9S_B_TOPB1160_1","DIHYDROFOLATE REDUCTASE TYPE 1 FROM TN4003","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",5,"LEU A 500;LEU A 528;ILE A 491;PHE A 438;THR A 463","None","0.94A","2w9sB-3nheA:undetectable","2w9sB-3nheA:20.93"],["2W9S_D_TOPD1158_1","DIHYDROFOLATE REDUCTASE TYPE 1 FROM TN4003","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",5,"LEU A 500;LEU A 528;ILE A 491;PHE A 438;THR A 463","None","1.14A","2w9sD-3nheA:undetectable","2w9sD-3nheA:20.93"],["2W9S_F_TOPF1159_1","DIHYDROFOLATE REDUCTASE TYPE 1 FROM TN4003","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",5,"LEU A 500;LEU A 528;ILE A 491;PHE A 438;THR A 463","None","1.12A","2w9sF-3nheA:undetectable","2w9sF-3nheA:20.93"],["2ZVJ_A_SAMA301_1","CATECHOL O-METHYLTRANSFERASE","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"SER A 421;SER A 442;GLN A 359;ASP A 436","None","1.31A","2zvjA-3nheA:undetectable","2zvjA-3nheA:19.32"],["3AG2_C_CHDC271_0","CYTOCHROME C OXIDASE SUBUNIT 3","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"LEU A 419;GLN A 492;PHE A 438;LEU A 441","None","1.01A","3ag2C-3nheA:undetectable","3ag2C-3nheA:20.23"],["3LN1_D_CELD682_2","PROSTAGLANDIN G\/H SYNTHASE 2","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"LEU A 598;ARG A 493;ILE A 491;PHE A 494","None","1.23A","3ln1D-3nheA:undetectable","3ln1D-3nheA:21.36"],["3X2Q_C_CHDC304_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"LEU A 419;GLN A 492;PHE A 438;LEU A 441","None","0.93A","3x2qC-3nheA:undetectable;3x2qJ-3nheA:undetectable","3x2qC-3nheA:20.23;3x2qJ-3nheA:10.64"],["3X2Q_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"LEU A 419;GLN A 492;PHE A 438;LEU A 441","None","0.91A","3x2qP-3nheA:undetectable;3x2qW-3nheA:undetectable","3x2qP-3nheA:20.23;3x2qW-3nheA:10.64"],["4N09_A_ADNA401_2","ADENOSINE KINASE","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"LEU A 502;SER A 442;LEU A 593;LEU A 455","None","1.01A","4n09A-3nheA:undetectable","4n09A-3nheA:22.60"],["4OBW_A_SAMA602_1","2-METHOXY-6-POLYPRENYL-1,4-BENZOQUINOL METHYLASE, MITOCHONDRIAL","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",3,"ASP A 392;ASN A 535;SER A 421","None","0.86A","4obwA-3nheA:undetectable","4obwA-3nheA:21.98"],["5B1A_C_CHDC304_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"LEU A 419;GLN A 492;PHE A 438;LEU A 441","None","0.94A","5b1aC-3nheA:undetectable;5b1aJ-3nheA:undetectable","5b1aC-3nheA:20.23;5b1aJ-3nheA:10.64"],["5B1A_P_CHDP305_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"LEU A 419;GLN A 492;PHE A 438;LEU A 441","None","0.87A","5b1aP-3nheA:undetectable;5b1aW-3nheA:undetectable","5b1aP-3nheA:20.23;5b1aW-3nheA:10.64"],["5B3S_C_CHDC307_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"LEU A 419;GLN A 492;PHE A 438;LEU A 441","None","0.90A","5b3sC-3nheA:undetectable;5b3sJ-3nheA:undetectable","5b3sC-3nheA:20.23;5b3sJ-3nheA:10.64"],["5B3S_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 3","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"LEU A 419;GLN A 492;PHE A 438;LEU A 441","None","0.90A","5b3sP-3nheA:undetectable","5b3sP-3nheA:20.23"],["5EVY_X_SALX502_1","SALICYLATE HYDROXYLASE","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"SER A 286;GLN A 283;LEU A 266;PHE A 573","None","1.27A","5evyX-3nheA:undetectable","5evyX-3nheA:21.34"],["5FHR_B_SAMB303_1","CATECHOL O-METHYLTRANSFERASE","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"SER A 421;SER A 442;GLN A 359;ASP A 436","None","1.32A","5fhrB-3nheA:undetectable","5fhrB-3nheA:19.66"],["5IL1_A_SAMA601_0","METTL3","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",5,"ILE A 343;LEU A 282;GLU A 360;PHE A 361;ARG A 363","None","1.18A","5il1A-3nheA:undetectable","5il1A-3nheA:17.96"],["5IY5_C_CHDC307_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"LEU A 419;GLN A 492;PHE A 438;LEU A 441","None","0.87A","5iy5C-3nheA:undetectable;5iy5J-3nheA:undetectable","5iy5C-3nheA:21.04;5iy5J-3nheA:10.67"],["5XU8_A_DX4A701_0","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",7,"GLY A 268;LEU A 269;ASN A 279;SER A 280;GLN A 283;ALA A 560;PHE A 573","None;None;CME A 276 ( 4.0A);CME A 276 ( 4.5A);None;None;None","0.10A","5xu8A-3nheA:49.3","5xu8A-3nheA:100.00"],["5Z84_C_CHDC307_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"LEU A 419;GLN A 492;PHE A 438;LEU A 441","None","0.93A","5z84C-3nheA:undetectable;5z84J-3nheA:undetectable","5z84C-3nheA:20.23;5z84J-3nheA:10.64"],["5Z85_C_CHDC306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"LEU A 419;GLN A 492;PHE A 438;LEU A 441","None","0.94A","5z85C-3nheA:undetectable;5z85J-3nheA:undetectable","5z85C-3nheA:20.23;5z85J-3nheA:10.64"],["5ZCO_C_CHDC306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"LEU A 419;GLN A 492;PHE A 438;LEU A 441","None","0.92A","5zcoC-3nheA:undetectable;5zcoJ-3nheA:undetectable","5zcoC-3nheA:20.23;5zcoJ-3nheA:10.64"],["5ZCQ_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3nhe","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2","Homo sapiens",4,"LEU A 419;GLN A 492;PHE A 438;LEU A 441","None","0.92A","5zcqP-3nheA:undetectable;5zcqW-3nheA:undetectable","5zcqP-3nheA:20.23;5zcqW-3nheA:10.64"]]